These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1981225)

  • 1. Renal excretion of oxalate in patients with chronic renal failure or nephrolithiasis.
    Chen SM; Chen TW; Lee YH; Chu WY; Young TK
    J Formos Med Assoc; 1990 Aug; 89(8):651-6. PubMed ID: 1981225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal excretion of citrate in patients with chronic renal failure or nephrolithiasis.
    Chen SM; Chung LC; Lee YH; Young TK
    J Formos Med Assoc; 1991 Jan; 90(1):41-7. PubMed ID: 1679108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of increased oxalate absorption in patients with calcium-containing renal stones.
    Hodgkinson A
    Clin Sci Mol Med; 1978 Mar; 54(3):291-4. PubMed ID: 630804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Minar E
    Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal clearance of [14C]oxalate: comparison of constant-infusion with single-injection techniques.
    Prenen JA; Boer P; Mees EJ; Endeman HJ; Spoor SM; Oei HY
    Clin Sci (Lond); 1982 Jul; 63(1):47-51. PubMed ID: 7083764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis.
    Gambaro G; Petrarulo M; Nardelotto A; Marangella M; Baggio B
    Kidney Int; 1995 Nov; 48(5):1549-52. PubMed ID: 8544412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects.
    Lindsjö M; Danielson BG; Fellström B; Ljunghall S
    Scand J Urol Nephrol; 1989; 23(1):55-9. PubMed ID: 2922580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.
    Worcester EM; Nakagawa Y; Bushinsky DA; Coe FL
    J Clin Invest; 1986 Jun; 77(6):1888-96. PubMed ID: 3711339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal tubular function in children with hypercalciuria].
    Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
    Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
    Prié D; Ravery V; Boccon-Gibod L; Friedlander G
    Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake.
    Stitchantrakul W; Sopassathit W; Prapaipanich S; Domrongkitchaiporn S
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1028-33. PubMed ID: 15916110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal excretion of zinc in patients with chronic uremia.
    Chen SM; Chen TW; Young TK
    J Formos Med Assoc; 1990 Mar; 89(3):220-4. PubMed ID: 1974595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients].
    Caravaca F; Ruiz AB; Escola JM; Hernández Gallego R; Cerezo I; Fernández N; Barroso S; Martín MV
    Nefrologia; 2007; 27(4):466-71. PubMed ID: 17944584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease.
    Schwille PO; Hanisch E; Scholz D
    J Urol; 1984 Oct; 132(4):650-5. PubMed ID: 6471206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of uric acid in calcium oxalate nephrolithiasis].
    Hartung R
    MMW Munch Med Wochenschr; 1975 Mar; 117(10):387-90. PubMed ID: 804601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperoxaluria and renal calculi].
    Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
    Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.